Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > News > Kereos' Collaborators Present on Targeted Therapies

November 17th, 2005

Kereos' Collaborators Present on Targeted Therapies

Abstract:
Kereos, a biotechnology company developing targeted imaging agents and therapeutics to improve the detection and treatment of cancer and cardiovascular disease, announced today that the company's collaborators at Washington University School of Medicine will be presenting preclinical data on two therapeutic candidates at the American Heart Association (AHA) Scientific Sessions this week.

Source:
drugnewswire.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

New Nanodrug Produced in Iran from Milk Thistle May 4th, 2015

Antibacterial Ceramic Nanoparticles, Appropriate Material for Medical Devices May 3rd, 2015

Polymeric Nanocarriers Improve Performance of Anticancer Drugs April 30th, 2015

A phone with the ultimate macro feature: New attachment turns a smartphone into a microscope that can image and size DNA molecules 50,000 times thinner than a human hair April 29th, 2015

Announcements

From brittle to plastic in 1 breath: Rice University theorists show environments can alter 2-D materials' basic properties May 4th, 2015

Nanoparticles in consumer products can significantly alter normal gut microbiome May 4th, 2015

New Nanodrug Produced in Iran from Milk Thistle May 4th, 2015

Antibacterial Ceramic Nanoparticles, Appropriate Material for Medical Devices May 3rd, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project